27 results match your criteria: "Inner Mongolia Autonomous Region Cancer Hospital[Affiliation]"
Clusterin role in hepatocellular carcinoma patients treated with oxaliplatin.
Biosci Rep
February 2020
Department of General Surgery, Inner Mongolia Autonomous Region Cancer Hospital and The Affiliated People's Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous Region, 010059, China.
Aim: To explore the prognostic value of clusterin (CLU) in hepatocellular carcinoma (HCC) patients treated with oxaliplatin (OXA).
Methods: Relative expression of plasma CLU mRNA was examined via fluorescence quantitative real-time PCR (qRT-PCR), and CLU protein level in tissue samples was detected through immunohistochemistry. Chi-square test was used to analyze the relationship between CLU mRNA expression and clinical features of HCC patients treated with OXA.
WBSCR22 Competes with Long Non-coding RNA Linc00346 for miR-509-5p Binding Site to Regulate Cancer Stem Cell Phenotypes of Colorectal Cancer.
Biochem Genet
June 2020
Hepatobiliay Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 646000, Sichuan, China.
Various Long non-coding RNAs (lncRNAs) and MicroRNAs (miRNAs) have been demonstrated to be involved in colorectal cancer stem cells (CSCs). WBSCR22 is a key gene we previously found that functions in colorectal cancer (CRC). This paper aims to investigate the effects of WBSCR22 and its corresponding miRNA and lncRNA in CRC.
View Article and Find Full Text PDF